The Medicines and Healthcare products Regulatory Agency (MHRA) has authorized orforglipron, making the UK the first country in Europe to approve this GLP-1 tablet for weight management and type 2 diabetes. This medication is intended for adults with a BMI of 30 or above, or betw…
A recent study presented at the American Society for Nutrition's annual meeting suggests that genetic differences may play a significant role in individual food preferences, parti…
A recent study conducted at Beirut Arab University found that nearly half of the female students surveyed reported experiencing moderate-to-severe premenstrual syndrome (PMS), wit…
A recent study funded by the NIH has uncovered how newer oral GLP-1 drugs, including orforglipron and danuglipron, affect the brain's reward circuits in mice, potentially reducing…
Polycystic Ovary Syndrome (PCOS) significantly affects women's metabolic health, leading to increased food cravings and obesity. This article examines the hormonal disruptions in…